Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MonkeyVax: MVA Vaccine for Monkeypox Prevention
NCT05438953Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Primary completion
- Oct 2024
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label trial of JYNNEOS in mpox (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Proportion of failure of MVA vaccine at 3 months. Status: unknown.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on NCT05438953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438953.